Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.2B | 2.1B | 2.0B |
Cost of revenue | 539M | 530M | 511M | 489M |
Gross profit | 1.7B | 1.6B | 1.6B | 1.5B |
Operating expense | ||||
Research & development | 674M | 647M | 649M | 656M |
Selling general and admin | 839M | 818M | 814M | 781M |
Other operating expenses | — | — | — | — |
Operating income | 159M | 165M | 111M | 64M |
Non operating interest income | ||||
Income | 83M | 86M | 88M | 93M |
Expense | 28M | 29M | 28M | 29M |
Other income expense | -94M | 5M | -3M | -5M |
Pretax income | 120M | 227M | 168M | 123M |
Tax provision | 26M | 34M | 36M | 16M |
Net income | 94M | 193M | 132M | 107M |
Basic EPS | — | 0.7 | 0.5 | 0.4 |
Diluted EPS | — | 0.7 | 0.5 | 0.4 |
Basic average shares | — | 265.4M | 265.3M | 264.4M |
Diluted average shares | — | 268.5M | 267.9M | 270.3M |
EBITDA | 239M | 337M | 275M | 227M |
Net income from continuing op. | 94M | 193M | 132M | 107M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |